Oncology

Review of the most recent evidence-based literature discussing breast, colorectal, lung, and ovarian cancers, in addition to melanoma and multiple myeloma.

How Much Do We Spend and How Can We Spend It Better?

Insights Into Value-Based Insurance Design in Oncology

Radical Changes in Payment Incentives and Elimination of Low-Value Care

Health Plans Continue to Seek Methods to Curtail Cancer Costs

Grim Reality Is a Bitter Pill to Swallow: Interview with Michael P. Link, MD, ASCO President

The Challenges Facing Oncologists Are Formidable

Researchers who set off a firestorm in 2009 when they questioned the need for all adult men to undergo annual prostate cancer screenings have updated their findings.

This study critically assessed the published clinical and economic evidence supporting oncology orphan drugs marketed in the United States.